Curaleaf Holdings (CURLF) Other Working Capital Changes (2019 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Other Working Capital Changes of -$7.1 million for Q4 2024, down 705.91% year-over-year from $1.2 million in Q1 2024, and down 166.42% quarter-over-quarter from -$2.7 million in Q3 2024.
Curaleaf Holdings (CURLF) Other Working Capital Changes (2019 - 2024) Analysis & Trends
Curaleaf Holdings' Other Working Capital Changes history runs 6 years deep, the most recent figure standing at -$7.1 million for Q4 2024.
- In Q4 2024, Other Working Capital Changes fell 705.91% year-over-year to -$7.1 million; the TTM figure through Dec 2024 stood at -$12.1 million (down 6.23% YoY), while the FY2025 annual figure was -$17.9 million, down 9.27% from the prior year.
- Other Working Capital Changes for Q4 2024 stood at -$7.1 million, down from -$2.7 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $13.8 million in Q4 2023, with the low at -$15.9 million in Q1 2021.
- The 5-year median for Other Working Capital Changes is $566500.0 (2020), against an average of -$649875.0.
- The sharpest annual moves came in 2020 and 2021: Other Working Capital Changes sank 1682.44% in 2020, then jumped 1958.42% in 2021.
- Curaleaf Holdings' Other Working Capital Changes stood at -$23.2 million in 2020, then surged by 109.67% to $2.2 million in 2021, then tumbled by 184.74% to -$1.9 million in 2022, then jumped by 53.78% to -$880000.0 in 2023, then tumbled by 705.91% to -$7.1 million in 2024.
- Business Quant data shows CURLF's Other Working Capital Changes at -$7.1 million in Q4 2024, -$2.7 million in Q3 2024, and -$880000.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.09 Mn |
| Dec 31, 2024 | -2.09 Mn |
| Dec 31, 2024 | -2.09 Mn |
| Sep 30, 2024 | 1.77 Mn |
| Sep 30, 2024 | 1.77 Mn |
| Sep 30, 2024 | 1.77 Mn |
| Dec 31, 2023 | 13.79 Mn |
| Dec 31, 2023 | 13.79 Mn |
| Dec 31, 2023 | 13.79 Mn |
| Sep 30, 2023 | 549,000.00 |
| Sep 30, 2023 | 549,000.00 |
| Sep 30, 2023 | 549,000.00 |
| Dec 31, 2022 | 838,000.00 |
| Dec 31, 2022 | 838,000.00 |
| Dec 31, 2022 | 838,000.00 |
| Sep 30, 2022 | 293,000.00 |
| Sep 30, 2022 | 293,000.00 |
| Sep 30, 2022 | 293,000.00 |
| Jun 30, 2022 | 3.71 Mn |
| Jun 30, 2022 | 3.71 Mn |